Exploring the lipoprotein composition using Bayesian regression on serum lipidomic profiles

MOTIVATION Serum lipids have been traditionally studied in the context of lipoprotein particles. Today's emerging lipidomics technologies afford sensitive detection of individual lipid molecular species, i.e. to a much greater detail than the scale of lipoproteins. However, such global serum lipidomic profiles do not inherently contain any information on where the detected lipid species are coming from. Since it is too laborious and time consuming to routinely perform serum fractionation and lipidomics analysis on each lipoprotein fraction separately, this presents a challenge for the interpretation of lipidomic profile data. An exciting and medically important new bioinformatics challenge today is therefore how to build on extensive knowledge of lipid metabolism at lipoprotein levels in order to develop better models and bioinformatics tools based on high-dimensional lipidomic data becoming available today. RESULTS We developed a hierarchical Bayesian regression model to study lipidomic profiles in serum and in different lipoprotein classes. As a background data for the model building, we utilized lipidomic data for each of the lipoprotein fractions from 5 subjects with metabolic syndrome and 12 healthy controls. We clustered the lipid profiles and applied a regression model within each cluster separately. We found that the amount of a lipid in serum can be adequately described by the amounts of lipids in the lipoprotein classes. In addition to improved ability to interpret lipidomic data, we expect that our approach will also facilitate dynamic modelling of lipid metabolism at the individual molecular species level.

[1]  Yan Lu,et al.  Lipid mediator informatics-lipidomics: Novel pathways in mapping resolution , 2006, The AAPS Journal.

[2]  Christian P. Robert,et al.  Monte Carlo Statistical Methods , 2005, Springer Texts in Statistics.

[3]  I. Wilson,et al.  Metabonomics, dietary influences and cultural differences: a 1H NMR-based study of urine samples obtained from healthy British and Swedish subjects. , 2004, Journal of pharmaceutical and biomedical analysis.

[4]  P. Green Reversible jump Markov chain Monte Carlo computation and Bayesian model determination , 1995 .

[5]  Arnold Zellner,et al.  Prediction and Decision Problems in Regression Models from the Bayesian Point of View , 1965 .

[6]  Markus R. Wenk,et al.  The emerging field of lipidomics , 2005 .

[7]  Eoin Fahy,et al.  A comprehensive classification system for lipids11 The evaluation of this manuscript was handled by the former Editor-in-Chief Trudy Forte. Published, JLR Papers in Press, February 16, 2005. DOI 10.1194/jlr.E400004-JLR200 , 2005, Journal of Lipid Research.

[8]  D. Kell Metabolomics, modelling and machine learning in systems biology – towards an understanding of the languages of cells , 2006, The FEBS journal.

[9]  I. Wilson,et al.  Gut microorganisms, mammalian metabolism and personalized health care , 2005, Nature Reviews Microbiology.

[10]  Matej Oresic,et al.  Bioinformatics strategies for lipidomics analysis: characterization of obesity related hepatic steatosis , 2007, BMC Systems Biology.

[11]  Matej Oresic,et al.  Processing methods for differential analysis of LC/MS profile data , 2005, BMC Bioinformatics.

[12]  Matej Orešič,et al.  The Role of Metabolomics in Systems Biology , 2003 .

[13]  S. Walker Invited comment on the paper "Slice Sampling" by Radford Neal , 2003 .

[14]  L. Joseph 4. Bayesian data analysis (2nd edn). Andrew Gelman, John B. Carlin, Hal S. Stern and Donald B. Rubin (eds), Chapman & Hall/CRC, Boca Raton, 2003. No. of pages: xxv + 668. Price: $59.95. ISBN 1‐58488‐388‐X , 2004 .

[15]  Radford M. Neal Slice Sampling , 2003, The Annals of Statistics.

[16]  R. A. van den Berg,et al.  Centering, scaling, and transformations: improving the biological information content of metabolomics data , 2006, BMC Genomics.

[17]  Matej Orešič,et al.  The role of metabolomics in systems biology : a new vision for drug discovery and development , 2003 .

[18]  R. Goodacre,et al.  Metabolic Profiling: Its Role in Biomarker Discovery and Gene Function Analysis , 2003, Springer US.

[19]  Aldons J. Lusis,et al.  A thematic review series: systems biology approaches to metabolic and cardiovascular disorders , 2006, Journal of Lipid Research.

[20]  Marko Sysi-Aho,et al.  Acquired Obesity Is Associated with Changes in the Serum Lipidomic Profile Independent of Genetic Effects – A Monozygotic Twin Study , 2007, PloS one.

[21]  A. Watson,et al.  Thematic Review Lipidomics: a Global Approach to Lipid Analysis in Biological Systems , 2022 .

[22]  Matej Oresic,et al.  MZmine: toolbox for processing and visualization of mass spectrometry based molecular profile data , 2006, Bioinform..

[23]  Douglas B Kell,et al.  Theodor Bücher Lecture. Metabolomics, modelling and machine learning in systems biology - towards an understanding of the languages of cells. Delivered on 3 July 2005 at the 30th FEBS Congress and the 9th IUBMB conference in Budapest. , 2006, The FEBS journal.

[24]  Sylvia Richardson,et al.  Inference and monitoring convergence , 1995 .

[25]  D. Illingworth,et al.  Lipoproteins in Health and Diseases , 1999 .

[26]  D. Moller,et al.  Metabolic syndrome: a clinical and molecular perspective. , 2005, Annual review of medicine.

[27]  Matej Oresic,et al.  Normalization method for metabolomics data using optimal selection of multiple internal standards , 2007, BMC Bioinformatics.

[28]  Arnold Zellner,et al.  On the Bayesian Estimation of Multivariate Regression , 1964 .

[29]  A. Gelman Prior distributions for variance parameters in hierarchical models (comment on article by Browne and Draper) , 2004 .

[30]  A. B. Robinson,et al.  Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[31]  S. Grundy,et al.  Kinetic model for production and metabolism of very low density lipoprotein triglycerides. Evidence for a slow production pathway and results for normolipidemic subjects. , 1979, The Journal of clinical investigation.

[32]  Bernt Wennberg,et al.  A new combined multicompartmental model for apolipoprotein B-100 and triglyceride metabolism in VLDL subfractions Published, JLR Papers in Press, October 16, 2004. DOI 10.1194/jlr.M400108-JLR200 , 2005, Journal of Lipid Research.

[33]  D. Vance,et al.  Biochemistry of Lipids, Lipoproteins and Membranes , 2002 .

[34]  David B. Dunson,et al.  Bayesian Data Analysis , 2010 .

[35]  Marko Sysi-Aho,et al.  A Systems Biology Strategy Reveals Biological Pathways and Plasma Biomarker Candidates for Potentially Toxic Statin-Induced Changes in Muscle , 2006, PloS one.

[36]  M. Orešič,et al.  Metabolomic approaches to phenotype characterization and applications to complex diseases , 2006, Expert review of molecular diagnostics.

[37]  Sylvia Richardson,et al.  Markov Chain Monte Carlo in Practice , 1997 .